6 patents currently held
22 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in May 2027. from the record
Of the 22 now held by other companies, 22 name Jenavalve Technology Inc. as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
6
Ending by 2030
May 2027
Next term end
2
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Only 2 of the currently held patents qualify as notable.
Notable
Ends Feb 2028 · High confidence
Also notable
Ends May 2027 · Low confidence
Stent for the Positioning and Anchoring of a Valvular Prosthesis in an Implantation Site in the Heart of a Patient
US 8,790,395
The most cited patent in this portfolio, cited by 227 later US patents, top 5% of utility patents granted in 2014 in our data. Protection runs to 2028. A terminal disclaimer caps this term to an earlier patent's.
Device for the Implantation and Fixation of Prosthetic Valves
US RE45,790
The largest patent family in this portfolio, 7 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Formerly held, still cited
Notable
Ends Mar 2032 · High confidence
Cited by 368 later US patents, top 1% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2032.
now held by Jenavalve Technology, Inc.
Also notable
Ends Aug 2029 · High confidence
Cited by 581 later US patents, top 1% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2029.
now held by Jenavalve Technology, Inc.
Also notable
Ends Jan 2031 · High confidence
Cited by 842 later US patents, top 1% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2031.
now held by Jenavalve Technology, Inc.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Sep 3, 2027The maintenance fee for Stent for the Positioning and Anchoring of a Valvular Prosthesis in an Implantation Site in the Heart of a Patient (US 10,575,947) comes due Sep 3, 2027. Unpaid by Mar 3, 2028, it lapses early.
Recent changes
- 5 terms have ended since Aug 18, 2026
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
Patents held now
Soonest term end first.
Showing 1 to 6 of 6
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US RE45,790 | Device for the Implantation and Fixation of Prosthetic Valves In force · Low confidence | In force | Low confidence | |
| US 8,790,395 | Stent for the Positioning and Anchoring of a Valvular Prosthesis in an Implantation Site in the Heart of a Patient In force · High confidence | In force | High confidence | |
| US 9,439,759 | Endoprosthesis for Implantation in the Heart of a Patient In force · High confidence | In force | High confidence | |
| US 9,867,699 | Endoprosthesis for Implantation in the Heart of a Patient In force · High confidence | In force | High confidence | |
| US 12,232,957 | Stent for the Positioning and Anchoring of a Valvular Prosthesis in an Implantation Site in the Heart of a Patient In force · Medium confidence | In force | Medium confidence | |
| US 10,575,947 | Stent for the Positioning and Anchoring of a Valvular Prosthesis in an Implantation Site in the Heart of a Patient In force · High confidence | In force | High confidence |
Also on record, not counted in the 6: 22 patents in force now held by others · 25 patents ended · 9 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
1 patents carry no fee events. That is a gap in the record, not evidence of lapse, so status falls back to the computed term